Transaction DateRecipientSharesTypePriceValue
6th January 2021Capital, Llc Armistice0Open or private purchase$0.00
6th January 2021Capital, Llc Armistice1,531,101Open or private purchase$5.23$8,000,002.73
4th December 2020Capital, Llc Armistice0Open or private purchase$0.00
4th December 2020Capital, Llc Armistice5,400Open or private purchase$4.13$22,302.00
3rd December 2020Capital, Llc Armistice0Open or private purchase$0.00
3rd December 2020Capital, Llc Armistice20,000Open or private purchase$2.44$48,800.00
2nd December 2020Capital, Llc Armistice1,000Open or private purchase$4.31$4,310.00
2nd December 2020Capital, Llc Armistice0Open or private purchase$0.00
25th November 2020Capital, Llc Armistice0Open or private purchase$0.00
25th November 2020Capital, Llc Armistice15,000Open or private purchase$2.39$35,850.00
Bio Path Holdings
Bio Path Holdings logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 10/10.


Bio-Path Holdings, Inc. is a biotechnology company. The company was founded by Peter Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007.


Ticker: BPTH
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1133818
Employees: 9
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals